Nuclear epidermal growth factor receptor as a therapeutic target
Epidermal growth factor receptor (EGFR) is one of the most well-studied oncogenes with roles in proliferation, growth, metastasis, and therapeutic resistance. This intense study has led to the development of a range of targeted therapeutics including small-molecule tyrosine kinase inhibitors (TKIs),...
Saved in:
Main Authors: | Benjamin Atwell (Author), Pavani Chalasani (Author), Joyce Schroeder (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
by: Lili Sheng, et al.
Published: (2021) -
Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020) -
Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication
by: Yuran Qiu, et al.
Published: (2021) -
Modulation of Pathological Pain by Epidermal Growth Factor Receptor
by: Jazlyn P. Borges, et al.
Published: (2021) -
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
by: ZiYan Yang, et al.
Published: (2021)